VILLANI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 1.258
EU - Europa 478
AS - Asia 103
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 1.872
Nazione #
US - Stati Uniti d'America 1.235
IT - Italia 233
NL - Olanda 105
CN - Cina 73
DE - Germania 48
CI - Costa d'Avorio 30
SE - Svezia 24
CA - Canada 18
IE - Irlanda 16
FI - Finlandia 12
GB - Regno Unito 10
IN - India 10
UA - Ucraina 7
FR - Francia 5
MX - Messico 5
VN - Vietnam 5
RO - Romania 4
SG - Singapore 4
CZ - Repubblica Ceca 3
JP - Giappone 3
TW - Taiwan 3
BG - Bulgaria 2
DK - Danimarca 2
HU - Ungheria 2
KR - Corea 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
EU - Europa 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
PK - Pakistan 1
PL - Polonia 1
Totale 1.872
Città #
Chandler 321
Ashburn 121
Amsterdam 101
Lawrence 82
Napoli 76
Boston 74
Millbury 70
Des Moines 46
Wilmington 30
Beijing 28
Naples 26
Nanjing 21
Washington 20
Kronberg 15
Ottawa 11
Fairfield 9
Latina 9
Rome 9
Dublin 8
Lappeenranta 8
Los Angeles 7
Woodbridge 7
Houston 6
Princeton 6
Santa Clara 6
Seattle 6
Cagliari 5
Grammichele 5
Hebei 5
Milan 5
Pune 5
Dong Ket 4
Frankfurt am Main 4
Freiburg im Breisgau 4
Jiaxing 4
Krefeld 4
Meppel 4
Mexico City 4
Avella 3
Edinburgh 3
Jacksonville 3
Kagoya 3
Magenta 3
Nanchang 3
Paris 3
Prague 3
Santa Maria La Carita 3
Shenyang 3
Taipei 3
Ann Arbor 2
Arezzo 2
Asti 2
Bergamo 2
Boardman 2
Bologna 2
Budapest 2
Buffalo 2
Castellammare di Stabia 2
Copenhagen 2
Council Bluffs 2
Dallas 2
Frattamaggiore 2
Golasecca 2
Norwalk 2
Orta Nova 2
Padova 2
Redwood City 2
Sarno 2
Sofia 2
Stockholm 2
Tianjin 2
Trecase 2
Altavilla Irpina 1
Angri 1
Bacoli 1
Bad Bellingen 1
Brussels 1
Bucharest 1
Caivano 1
Cambridge 1
Casalbore 1
Caserta 1
Changsha 1
Chengdu 1
Coquitlam 1
Cosenza 1
Daejeon 1
Dubai 1
Florence 1
Fort St. James 1
Fremont 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Indore 1
Kisa 1
Kyiv 1
Lagos 1
Leporano 1
London 1
Totale 1.283
Nome #
A case of the co-existence of subcorneal pustular dermatosis and pyoderma gangrenosum and a review of the literature 46
Complete remission of an advanced basal cell carcinoma after only 3-month treatment with sonidegib: Report of a case and drug management during COVID-19 pandemic 43
Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose 43
Psoriasis in a cohort of patients with common variable immunodeficiency 41
Cutaneous leucocytoclastic vasculitis during secukinumab treatment 41
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families 41
How reflectance confocal microscopy can help diagnose an enigmatic variant of dermatofibroma 40
Clinical and dermoscopic features of Spitz nevus by sex, age and anatomical site: a study of 913 Spitz naevi 37
Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study 37
Long-Term Efficacy of Vismodegib After its Withdrawal and Patients’ Health-Related Quality of Life Using the Dermatology Life Quality Index (DLQI) 36
Squamous Cell Carcinomas in Two Cases of Nail Lichen Planus: Is There a Real Association? 36
Reply to Woltsche N. et al. Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single center experience 35
Vismodegib treatment in a HIV positive patient on antiretroviral therapy 33
Leiomyoma of the finger in a patient affected by cutaneous Kaposi's sarcoma 32
Teledermoscopy: a promising tool in pediatric practice 32
Letter to the editor submitted in response to "psoriasis in pregnancy: case series and literature review of data concerning exposure during pregnancy to ustekinumab" 31
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies 31
Cutaneous Bowen’s disease: An analysis of 182 cases according to age, sex, and anatomical site from an Italian center 30
Effective and tolerable treatment of advanced basal cell carcinoma with vismodegib despite other malignancies 29
Dermoscopic patterns of intradermal naevi 28
It Is Not as It Seems 27
Efficacy and safety of a new topical gel formulation containing retinol encapsulated in glycospheres and hydroxypinacolone retinoate, an antimicrobial peptide, salicylic acid, glycolic acid and niacinamide for the treatment of mild acne: preliminary results of a 2-month prospective study 27
Reply to Wong C et al. "Comparison of daily dosing vs. Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma (laBCC) and basal cell nevus syndrome: a retrospective case series" 26
Assessment of the adverse events related to hedgehog pathway inhibitor therapy for basal cell carcinoma: A single-centre retrospective study 26
Use of Natural Agents and Agrifood Wastes for the Treatment of Skin Photoaging 25
Systemic Treatment of Pediatric Psoriasis: A Review. 25
The effectiveness of vismodegib in patients with advanced periocular basal cell carcinoma: a case series of 13 patients 25
Neutrophilic dermatosis in pregnancy: An uncommon course 24
Psoriasis Features in Patients with Inflammatory Bowel Disease 24
Teledermatology for acne during COVID-19: high patients' satisfaction in spite of the emergency 24
Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity 24
Grover disease in a young woman: report of case. 24
Awareness on sun protection behavior among melanoma and nonmelanoma skin cancer patients: An Italian tertiary cancer center experience 24
Alopecia universalis improvement following risankizumab in a psoriasis patient 24
Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period 23
Nail changes as manifestation of systemic disease in COVID‐19 infection 23
The remarkable increase of squamous cell carcinomas: a retrospective single-center study of 14-years study period 22
Efficacy and safety of vismodegib in patients with basal cell carcinoma: An Italian Center experience 22
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis 21
Reflectance confocal microscopy for Kaposi's sarcoma treatment monitoring after intralesional vincristine chemotherapy 21
Cutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective study 20
Phototherapy and vitamin D: the importance in COVID-19 era 20
Patients with bullous disorders during COVID-19 period: Management and adherence to treatment 20
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review 19
Therapeutic update of biologics and small molecules for scalp psoriasis: a systematic review 19
Systemic Treatment of Adult Atopic Dermatitis: A Review 18
Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test 18
Dermoscopy and reflectance confocal microscopy of Kaposi's sarcoma: an overview 18
Dermatophytid evaluated by in vivo reflectance confocal microscopy: a new approach? 18
Adalimumab biosimilar in a pediatric patient: clinical and in vivo reflectance confocal microscopy evaluation 17
Effects of COVID-19 pandemic on malignant melanoma diagnosis 17
Teledermatology for acne patients: How to reduce face-to-face visits during COVID-19 pandemic 17
Teledermatology: a useful tool also after Covid-19 era? 17
COVID-19 vaccination and inflammatory skin diseases 17
COVID-19 and cutaneous manifestations: A review of the published literature 16
Comment on: “Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring” 16
Community Knowledge About the Use, Reuse, Disinfection and Disposal of Masks and Filtering Facepiece Respirators: Results of a Study Conducted in a Dermatology Clinic at the University of Naples in Italy 16
Reply to ‘Impact of the French COVID ‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al 15
Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma 15
Telemedicine and support groups could be used to improve adherence to treatment and health-related quality of life in patients affected by inflammatory skin conditions during the COVID-19 pandemic 15
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature 14
Teledermatology in the management of hidradenitis suppurativa: Should we improve this service? 14
Tinea Capitis in Campania: A 5-Year Retrospective Study in Childhood and Adolescence (2013-2018). 14
Teledermatology and chronic skin diseases: real life experience in a Southern Italian Dermatologic Centre 14
Dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor sonidegib to manage adverse effects: A retrospective case series 14
Long-term results of teledermatology for acne patients during COVID-19 pandemic 14
Maskne prevalence and risk factors during the COVID-19 pandemic 13
Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study' by Bawane J et al 13
Second primary melanoma: incidence rate and risk factors 13
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma 12
Cutaneous reactions following booster dose of Covid-19 mRNA vaccination: what we should know 11
Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature 11
Trends in epidemiology of melanoma in situ in a center of South-Italy: Data from a melanoma reference center during the period 2004–2018 11
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on 'A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department' 10
Long-term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID-19 pandemic 10
The reduction in the detection of melanoma during the coronavirus disease 2019 (COVID-19) pandemic in a melanoma center of South Italy 10
Psoriasis awareness among general population: preliminary results of an online survey 10
The impact of COVID-19 pandemic on nonmelanoma skin cancers: report of a Southern Italy referral centre 9
Viral Reactivation Following COVID-19 Vaccination: a review of the current literature 9
Teledermatology: a useful tool to fight COVID-19 9
SMS support group in the management of acne: A useful tool to increase adherence to treatment 9
Letter to the editor regarding article "Gu L, Diaz SM, Lipner SR. Retrospective study of acne telemedicine and in-person visits at an academic center during the COVID-19 pandemic. J Cosmet Dermatol. 2022;21(1):36-38." 9
Cutaneous adverse reaction following COVID-19 vaccination: Report from a southern Italian referral centre. Comment on "cutaneous adverse reactions following the Pfizer/BioNTech COVID-19 vaccine" by Luo et al 8
Patients with advanced basal cell carcinomas in treatment with sonic hedgehog inhibitors during the coronavirus disease 2019 (COVID-19) period: Management and adherence to treatment 8
Looking into a Better Future: Novel Therapies for Metastatic Melanoma 8
Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment 8
The Effect of the COVID-19 Lockdown on Melanoma Diagnosis in Italy 8
Resistance to hedgehog inhibitors in basal cell carcinoma: strategies to adopt 8
Letter to the editor regarding article "Hlaca N, Zagar T, Kastelan M, Peternel S, Brajac I, Prpic-Massari L. New-onset lichen planus and lichen planus flare in elderly women after COVID-19 vaccination. J Cosmet Dermatol. 2022;10.1111/jocd.15185" 7
Letter to the editor regarding article "Falotico JM, Gu L, Lipner SR. Not just pimple popping: The utility of hybrid telemedicine models beyond acne management amidst the ongoing COVID-19 pandemic. J Cosmet Dermatol. 2022;10.1111/jocd.15256" 7
Reply to: "Usage and perceptions of teledermatology in 2021: a survey of dermatologists" by Ahmad et al 7
Oral isotretinoin for acne: a complete overview 7
Hair Loss in Patients Treated with Vismodegib: A Single-Center Retrospective Study 7
Hedgehog inhibitors in the treatment of advanced basal cell carcinoma: risks and benefits 7
Skin needling for the treatment of acne scarring: A comprehensive review 7
Melanoma Screening Days During the Coronavirus Disease 2019 (COVID-19) Pandemic: Strategies to Adopt 7
Response to "Efficacy of sonidegib in histologic subtypes of advanced basal cell carcinoma: Results from the final analysis of the randomized phase 2 Basal Cell Carcinoma Outcomes with LDE225 Treatment (BOLT) trial at 42 months" 7
Vismodegib treatment in advanced basal cell carcinomas: Real-life experience 7
Sonidegib efficacy and tolerability in advanced basal cell carcinoma: A single-center real-life experience 7
Development of a Patient-Reported Outcome Measure (PROM) for Dysgeusia During Treatment With Smoothened (SMO) Inhibitors for Basal Cell Carcinomas: The SMO-iD Questionnaire 6
Totale 1.935
Categoria #
all - tutte 11.089
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.089


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 4 0 3
2019/2020126 37 1 3 13 1 0 3 0 7 14 35 12
2020/2021198 10 0 9 12 19 7 2 74 3 50 8 4
2021/2022415 0 0 4 2 2 20 18 18 17 35 99 200
2022/2023766 103 76 19 34 104 68 7 80 115 95 41 24
2023/2024502 28 105 65 37 41 87 10 67 34 28 0 0
Totale 2.058